Co-Authors
This is a "connection" page, showing publications co-authored by David Lye and Yee-Sin Leo.
Connection Strength
4.594
-
Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. Lancet. 2017 04 22; 389(10079):1611-1618.
Score: 0.707
-
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum Infect Dis. 2021 Jun; 8(6):ofab156.
Score: 0.234
-
Association of Higher Body Mass Index With Severe Coronavirus Disease 2019 (COVID-19) in Younger Patients. Clin Infect Dis. 2020 11 19; 71(16):2300-2302.
Score: 0.229
-
Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study. Clin Infect Dis. 2020 07 11; 71(2):383-389.
Score: 0.223
-
Hyperlipidemia, statin use and dengue severity. Sci Rep. 2018 11 21; 8(1):17147.
Score: 0.199
-
Differences in clinical features and dengue severity between local and migrant Chinese with dengue infection in Singapore. PLoS One. 2018; 13(8):e0201441.
Score: 0.195
-
Metformin Use and Severe Dengue in Diabetic Adults. Sci Rep. 2018 02 20; 8(1):3344.
Score: 0.189
-
Progress and Challenges towards Point-of-Care Diagnostic Development for Dengue. J Clin Microbiol. 2017 12; 55(12):3339-3349.
Score: 0.183
-
Clinical features of patients with Zika and dengue virus co-infection in Singapore. J Infect. 2017 06; 74(6):611-615.
Score: 0.177
-
Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: A matched case-control study. Sci Rep. 2017 01 03; 7:39872.
Score: 0.175
-
Risk factors for concurrent bacteremia in adult patients with dengue. J Microbiol Immunol Infect. 2017 Jun; 50(3):314-320.
Score: 0.158
-
Pandemic (H1N1) 2009: clinical and laboratory findings of the first fifty cases in Singapore. Ann Acad Med Singap. 2010 Apr; 39(4):267-6.
Score: 0.109
-
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clin Infect Dis. 2021 11 02; 73(9):e2932-e2942.
Score: 0.061
-
Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta). Clin Infect Dis. 2021 Aug 23.
Score: 0.060
-
Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors. N Engl J Med. 2021 10 07; 385(15):1401-1406.
Score: 0.060
-
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir. Front Immunol. 2021; 12:680188.
Score: 0.060
-
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2. EMBO Mol Med. 2021 06 07; 13(6):e14045.
Score: 0.059
-
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study. EBioMedicine. 2021 Apr; 66:103319.
Score: 0.059
-
Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore. Sci Rep. 2021 04 05; 11(1):7477.
Score: 0.059
-
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study. Lancet Microbe. 2021 Jun; 2(6):e240-e249.
Score: 0.058
-
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant. Clin Transl Immunology. 2021; 10(2):e1241.
Score: 0.058
-
Diagnostic performance of COVID-19 serological assays during early infection: A systematic review and meta-analysis of 11 516 samples. Influenza Other Respir Viruses. 2021 07; 15(4):529-538.
Score: 0.058
-
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19. Cell Rep Med. 2021 02 16; 2(2):100193.
Score: 0.058
-
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2. Emerg Microbes Infect. 2020 Dec; 9(1):900-902.
Score: 0.057
-
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat Commun. 2020 10 16; 11(1):5243.
Score: 0.057
-
Coronavirus Disease 2019 (COVID-19): The Singapore Experience. A Review of the First Eight Months. Ann Acad Med Singap. 2020 Oct; 49(10):764-778.
Score: 0.057
-
Radiographic features of COVID-19 based on an initial cohort of 96 patients in Singapore. Singapore Med J. 2021 09; 62(9):458-465.
Score: 0.056
-
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 2020 08 29; 396(10251):603-611.
Score: 0.056
-
Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Clin Transl Immunology. 2020; 9(7):e1160.
Score: 0.056
-
Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019. Clin Transl Immunology. 2020; 9(7):e1159.
Score: 0.056
-
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity. EBioMedicine. 2020 Aug; 58:102911.
Score: 0.056
-
Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2. mBio. 2020 07 21; 11(4).
Score: 0.056
-
Clinical utility of chest radiography for severe COVID-19. Quant Imaging Med Surg. 2020 Jul; 10(7):1540-1550.
Score: 0.056
-
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020 06 01; 11(1):2806.
Score: 0.055
-
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020 04 21; 323(15):1488-1494.
Score: 0.055
-
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 2020 03 28; 395(10229):1039-1046.
Score: 0.055
-
SARS-CoV-2 Infection among Travelers Returning from Wuhan, China. N Engl J Med. 2020 04 09; 382(15):1476-1478.
Score: 0.054
-
Hantavirus Inhibits TRAIL-Mediated Killing of Infected Cells by Downregulating Death Receptor 5. Cell Rep. 2019 08 20; 28(8):2124-2139.e6.
Score: 0.052
-
Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus. Front Immunol. 2018; 9:2225.
Score: 0.049
-
Distinguishing Zika and Dengue Viruses through Simple Clinical Assessment, Singapore. Emerg Infect Dis. 2018 08; 24(8):1565-1568.
Score: 0.049
-
Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus-Infected Patients. J Infect Dis. 2018 07 24; 218(5):814-824.
Score: 0.049
-
High Yield of HIV Testing in Dengue-Like Febrile Illness in Singapore. Open Forum Infect Dis. 2018 Aug; 5(8):ofy171.
Score: 0.049
-
Diagnostic Accuracy of Parameters for Zika and Dengue Virus Infections, Singapore. Emerg Infect Dis. 2017 12; 23(12):2085-2088.
Score: 0.047
-
A Sensitive Method for Detecting Zika Virus Antigen in Patients' Whole-Blood Specimens as an Alternative Diagnostic Approach. J Infect Dis. 2017 07 15; 216(2):182-190.
Score: 0.045
-
Medical and psychosocial factors associated with antibiotic prescribing in primary care: survey questionnaire and factor analysis. Br J Gen Pract. 2017 Mar; 67(656):e168-e177.
Score: 0.044